跳至主要内容
临床试验/NCT04884867
NCT04884867已完成不适用

"Sống Vui, Live Happily": A Psychosocial Tele-health Intervention to Address Multi-level Stigma Among Youth Living With HIV in Vietnam

University of New England1 个研究点 分布在 1 个国家目标入组 38 人开始时间: 2021年4月14日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
38
试验地点
1
主要终点
Intrapersonal (self) Stigma

研究概览

简要总结

The overall goals of the study are to deepen understanding of the spectrum of stigma experienced by YLHIV in Vietnam, to develop a multi-level stigma intervention for YLHIV delivered by telephone, and to evaluate the feasibility, acceptability, and preliminary efficacy of the intervention on intra- and inter-personal stigma, psychological wellbeing, and treatment adherence.

The project has the following Specific Aims:

  1. Adapt a psychosocial stigma-reduction intervention for YLHIV in Vietnam based on cognitive-behavioral therapy principles and delivered by telephone, using input from youth during intervention development.
  2. Assess the feasibility, acceptability and preliminary efficacy of this innovative approach to reduce stigma, and improve psychosocial wellbeing and ART adherence among YLHIV through a small pre-post study.
  3. Explore the multiple facets of stigma experienced by YLHIV in Vietnam and their relationships with ART adherence and psychosocial wellbeing via quantitative surveys and electronic adherence monitoring.

The study will assess the feasibility and acceptability of this approach among YLVIV in Vietnam, and generate preliminary evidence for the potential effect of the intervention on important endpoints including stigma, psychosocial wellbeing, adherence, CD4 count, and viral load (VL).

详细描述

For the pilot, the investigators will recruit YLHIV on ART who self-report intrapersonal stigma and implement a 12-week pre-post intervention study in which participants will receive the phone-based intervention developed in the first phase. YLHIV will use an electronic adherence monitoring device for their ART medications.

In the pre-post intervention study, each of 40 patients will be followed for a total of 16 weeks. All patient subjects will be given an eCAP wireless pill container (WPC) that will be used to measure their adherence throughout the 16-week period. Study participation will involve two phases, with the following activities:

I. Adherence monitoring, pre-intervention period (Weeks 1-2). Once enrolled, the investigators will provide each subject with a WPC and instruction on correct use. The investigators will select one medication for each WPC. While subjects continue to receive care as usual, the investigators will collect their adherence data using the WPC.

II. Intervention period (Weeks 3-12). The intervention will be implemented for about 10 weeks; adherence data will be collected via WPCs through Week 16. They will remain blinded to the adherence information generated by the devices, as will their care providers.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

盲法说明

Participants will use a wireless pill container to monitor their adherence passively. Participants, lay coaches, and clinicians will all be blinded to adherence monitoring.

入排标准

年龄范围
18 Years 至 24 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • are between 18 and 24 years old
  • are a patient at the OPC
  • are expected to remain in care at the OPC for 3 months minimum(?)
  • are currently on ART
  • have primary responsibility for taking their own medications,
  • self-report intrapersonal stigma via a brief screening questionnaire,
  • are able to complete a short phone call from the location where they intend to be when participating in coaching sessions,
  • agree to follow all study procedures, AND
  • provide informed consent.

排除标准

  • are below the age of 18 years or above the age of 24,
  • are not currently on ART,
  • live outside the clinic catchment area,
  • are identified as having severe mental health issues as identified through screening, OR
  • are not willing to provide informed consent.

结局指标

主要结局

Intrapersonal (self) Stigma

时间窗: change between Week 1-Week 12

modified 21-item self stigma subscale of Vietnam Stigma Index Studies instrument (People living with HIV: Stigma Index 2014; higher score=worse outcome)

Interpersonal Stigma

时间窗: change between Week 1 and Week 12

modified 21-item enacted stigma subscale of Vietnam Stigma Index Studies instrument (People living with HIV: Stigma Index 2014; higher score=worse outcome)

Adherence

时间窗: Week 12 (endline)

%≥95% on-time adherence

Depression

时间窗: change between Week 1 and Week 12

7-item depression subscale of the Depression, Anxiety and Stress Scale (DASS-21; higher score=worse outcome)

Anxiety

时间窗: change between Week 1 and Week 12

7-item depression subscale of the Depression, Anxiety and Stress Scale (DASS-21; higher score=worse outcome)

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mary DeSilva

Associate Research Professor

University of New England

研究点 (1)

Loading locations...

相似试验